Biblio Discovery — Demo Discovery Service

15 hasil untuk "Devis, Benfaremo"

Menampilkan 1–15 · 0,42 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?

    Devis Benfaremo; Armando Gabrielli

    Cells, Vol. 9 No. 1 · 2019 · Inggris · DOAJ Scopus

    CD38 is a type II glycoprotein highly expressed on plasmablasts, short-lived and long-lived plasma cells, but weakly expressed on other lymphoid cells, myeloid cells and non-hematopoietic cells. This expression pattern makes CD38 an interesting target for a targeted therapy aiming to deplete…

  2. Artikel Jurnal

    Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs

    Devis Benfaremo; Michele Maria Luchetti; Armando Gabrielli

    Journal of Immunology Research, Vol. 2019 · 2019 · Inggris · DOAJ Scopus

    Inflammatory bowel disease-associated spondyloarthritis is a systemic disease characterized by the chronic inflammation of both the gastrointestinal tract and the musculoskeletal system. Since inflammatory bowel disease-associated spondyloarthritis has been associated with a significant diagnostic…

  3. Artikel Jurnal Teks lengkap

    Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches

    Devis Benfaremo; Silvia Svegliati; Chiara Paolini dkk.

    Biomedicines, Vol. 10 No. 1 · 2022 · Inggris · DOAJ Scopus

    Systemic sclerosis (SSc) is a systemic, immune-mediated chronic disorder characterized by small vessel alterations and progressive fibrosis of the skin and internal organs. The combination of a predisposing genetic background and triggering factors that causes a persistent activation of immune…

  4. Artikel Jurnal Teks lengkap

    A young man with persistent dyspepsia: the unexpected virtue of proton-pump inhibitors

    Paolo, Fraticelli; Massimo, Mattioli; Devis, Benfaremo dkk.

    Acta Biomed · 2018 · Inggris · PubMed Central

    A 26-year-old man was referred to our department for a 3-year history of dyspepsia responsive to oral pump-inhibitors therapy. During the last year, he underwent a gastroscopy, a colonoscopy and a computed tomography enterography that failed to reveal an underlying organic disease: a diagnosis of…

  5. Artikel Jurnal

    Isolated Aortitis Presenting with an Annoying Persistent Cough: A Case Report

    Michele Maria Luchetti; William Capeci; Matteo Rossini dkk.

    European Journal of Case Reports in Internal Medicine, Vol. 3 No. 2 · 2016 · Inggris · DOAJ Scopus

    Objectives: To report a case of idiopathic aortitis presenting with chronic cough. Materials and Methods: the Authors describe the case of a 72-year-old man with dry cough, worsening fatigue, weight loss and elevated systemic inflammatory markers. Results: A PET-CT scan showed diffuse thickening of…

  6. Artikel Jurnal Teks lengkap

    Systemic Sclerosis: A Key Model of Endothelial Dysfunction

    Vincenzo Zaccone; Lorenzo Falsetti; Silvia Contegiacomo dkk.

    Biomedicines, Vol. 13 No. 7 · 2025 · Inggris · DOAJ Scopus

    Systemic sclerosis (SSc) is a heterogeneous disease characterized by vascular alterations, immune dysregulation, and fibrosis. Solid evidence supports the hypothesis that endothelial dysfunction is the key player in SSc vascular injury and a critical factor concurring to the initiation of SSc…

  7. Artikel Jurnal

    Exploring potential VEGF receptor 2 inhibitors: a molecular modeling and pharmacophore-based screening approach

    Matteo Mozzicafreddo; Devis Benfaremo; Silvia Agarbati dkk.

    Scientific Reports, Vol. 16 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract The vascular endothelial growth factor (VEGF) receptor 2, a membrane tyrosine kinase receptor activated by VEGF-A, triggers endothelial cell proliferation, migration, survival, and angiogenesis. With the aim of identifying additional new ligands or acquiring novel information to craft…

  8. Artikel Jurnal

    SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study

    Michele Maria Luchetti Gentiloni; Valentino Paci; Valentina Marconi dkk.

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    ObjectivesThe relationship between infections or vaccine antigens and exacerbations or new onset of immune-mediated diseases (IMDs) has long been known. In this observational study, conducted during the COVID-19 pandemic, we evaluated the onset of clinical and laboratory immune manifestations…

  9. Artikel Jurnal Teks lengkap

    Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study

    Massimo Mattioli; Devis Benfaremo; Francesca Fulgenzi dkk.

    Clinical and Experimental Emergency Medicine, Vol. 9 No. 1 · 2022 · Inggris · DOAJ Scopus

    Objective The national health systems are currently facing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. We assessed the efficacy of outpatient management for patients with SARS-CoV-2 related pneumonia at risk of progression after discharge from the emergency…

  10. Artikel Jurnal Teks lengkap

    Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational Study

    Vincenzo Zaccone; Silvia Contegiacomo; Silvia Agarbati dkk.

    Biomedicines, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: Systemic sclerosis (SSc) is characterized by endothelial dysfunction leading to progressive vascular injury and fibrosis. While microvascular involvement is well established as an early disease feature, macrovascular disease has been historically underrecognized and poorly investigated…

  11. Artikel Jurnal Teks lengkap

    Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations

    Giuseppe Murdaca; Giovanni Noberasco; Dario Olobardi dkk.

    Vaccines, Vol. 9 No. 12 · 2021 · Inggris · DOAJ Scopus

    Systemic sclerosis (SSc) is a rare autoimmune inflammatory rheumatic disease. The prevalence of SSc ranges from 7 to 700 cases per million worldwide. Due to multiple organ involvement and constant inflammatory state, this group of patients presents an increased risk of infectious diseases. This…

  12. Artikel Jurnal

    Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study

    Michele Maria Luchetti Gentiloni; Valentino Paci; Antonio Carletto dkk.

    Arthritis Research & Therapy, Vol. 25 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Upadacitinib (UPA) is a selective JAK inhibitor recently approved for the treatment of psoriatic arthritis (PsA). In this post-approval study, we aimed to evaluate the effectiveness and safety of UPA over 24 weeks and identify clinical predictors of response, in a multicentric…

  13. Artikel Jurnal

    Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study

    Paolo Airo; Veronica Codullo; Elisabetta Zanatta dkk.

    RMD Open, Vol. 12 No. 2 · 2026 · Inggris · DOAJ Scopus

    Background Tocilizumab (TCZ) has shown beneficial effects on interstitial lung disease (ILD) in systemic sclerosis (SSc). We aimed to assess the real-life safety and effectiveness of TCZ on several SSc-related domains using data from a French-Italian multicentre cohort.Methods We conducted a…

  14. Artikel Jurnal

    Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study

    Marco Matucci-Cerinic; Corrado Campochiaro; Paolo Airo dkk.

    RMD Open, Vol. 9 No. 1 · 2023 · Inggris · DOAJ Scopus

    Introduction Nintedanib (NTD) has been shown to be effective in systemic sclerosis (SSc)-interstitial lung disease (ILD). Here we describe the efficacy and safety of NTD in a real-life setting.Methods Patients with SSc-ILD treated with NTD were retrospectively evaluated at 12 months prior to NTD…